Del 2 Specifika lymfomtyper Cytostatikaschema Aktuella studier

More documents

Recommendations

Info

Här finner ni aktuella vårdprogram, riktlinjer och rapporter: Onkologiskt centrum Västra sjukvårdsregionen Sahlgrenska Universitetssjukhus 413 45 GÖTEBORG Tfn 031 $ 343 90 60 Fax 031 $ 20 92 50 E-post mail@oc.gu.se Hemsida www.oc.gu.se © Onkologiskt centrum, Västra sjukvårdsregionen ISSN: 1652-4977 - 4 Onkologiskt centrum Göteborg 2004
Vårdprogram för maligna lymfom Del 2 Specifika lymfomtyper Cytostatikaschema Aktuella studier DIFFUST STORCELLIGT B-CELLSLYMFOM (DLBCL)............................................................................ 2 MEDIASTINALT B-CELLSLYMFOM.............................................................................................................. 4 FOLLIKULÄRT LYMFOM (FL) ........................................................................................................................ 5 TRANSFORMATION INDOLENT – AGGRESSIVT LYMFOM.................................................................. 6 KRONISK LYMFATISK LEUKEMI (B-KLL) OCH SMÅCELLIGT LYMFOCYTÄRT LYMFOM.... 7 PROLYMFOCYTLEUKEMI (B-PLL) ............................................................................................................. 10 LYMFOPLASMACYTÄRT LYMFOM OCH WALDENSTRÖMS MAKROGLOBULINEMI............. 10 MANTELCELLSLYMFOM (MCL).................................................................................................................. 11 MARGINALZONSLYMFOM (MZL)............................................................................................................... 13 HÅRCELLSLEUKEMI (HCL)........................................................................................................................... 14 EXTRANODALA LYMFOM ............................................................................................................................. 15 GASTROINTESTINALA LYMFOM .......................................................................................................................... 15 KUTANA LYMFOM ............................................................................................................................................... 16 LYMFOM I WALDEYERS SVALGRING OCH MUNHÅLA......................................................................................... 17 LYMFOM I THYREOIDEA...................................................................................................................................... 18 ORBITALT LYMFOM............................................................................................................................................. 18 TESTISLYMFOM ................................................................................................................................................... 19 PERIFERA T-CELLSLYMFOM....................................................................................................................... 19 PERIFERT T-CELLSLYMFOM, OSPECIFICERAD TYP ............................................................................................. 19 EXTRANODALT NK/T-CELLSLYMFOM NASAL TYP............................................................................................. 20 ANGIOIMMUNOBLASTISKT T-CELLSLYMFOM (AILD) ....................................................................................... 20 T-CELLSLYMFOM AV ENTEROPATITYP ............................................................................................................... 20 ANAPLASTISKT STORCELLIGT T-CELLSLYMFOM (ALCL) ................................................................................. 21 T-CELL PROLYMFOCYTLEUKEMI (T-PLL).......................................................................................................... 21 STORCELLIG GRANULERAD LYMFATISK LEUKEMI (T-LGL).............................................................................. 21 ADULT T-CELLSLEUKEMI/-LYMFOM (HTLV1+)................................................................................................ 22 BURKITTS LYMFOM ........................................................................................................................................ 22 T-LYMFOBLASTLYMFOM (T-LBL).............................................................................................................. 23 B-LYMFOBLASTLYMFOM (B-LBL).............................................................................................................. 23 HODGKINS LYMFOM....................................................................................................................................... 24 FAS II STUDIE HODGKIN TIDIGA STADIER (NORDISKA LYMFOMGRUPPEN 1999............................................... 26 CYTOSTATIKASCHEMA ................................................................................................................................. 27 AKTUELLA STUDIER (MARS 2004) .............................................................................................................. 37 REFERENSER...................................................................................................................................................... 39 Maligna lymfom
Page 3: R E G I O N A L A V Å R D P R O G
Page 7 and 8: Ålder ≤ 60 år • Lågrisk #0-1
Page 9 and 10: Follikulärt lymfom (FL) Allmänt F
Page 11 and 12: Kronisk lymfatisk leukemi (B-KLL) o
Page 13 and 14: Kronisk lymfatisk leukemi (B-KLL) o
Page 15 and 16: Mantelcellslymfom (MCL) Symptom av
Page 17 and 18: Marginalzonslymfom (MZL) Marginalzo
Page 19 and 20: Extranodala lymfom Gastrointestinal
Page 21 and 22: Extranodala lymfom Extrakorporeal f
Page 23 and 24: Perifera T-cellslymfom Vid aggressi
Page 25 and 26: Anaplastiskt storcelligt T-cellslym
Page 27 and 28: T-lymfoblastlymfom (T-LBL) T-lymfob
Page 29 and 30: Om stadium III/IV, ålder 16-60 år
Page 31 and 32: Cytostatikaschema Klorambucil - enl
Page 33 and 34: ALEMTUZUMAB Preparat Dos Administre
Page 35 and 36: Riktlinjer för fortsatt dosering a
Page 37 and 38: Etoposid sätts i 500 ml NaCl och g
Page 39 and 40: Cytostatikaschema Koncentrationsbes
Page 41 and 42: Aktuella studier (mars 2004) Primä
Page 43 and 44: Referenser Diffust storcelligt B-ce
Page 45 and 46: Transformation Lerner RE, Burns IJ.

Del 2 Specifika lymfomtyper Cytostatikaschema Aktuella studier

Create successful ePaper yourself

Delete template?

Save as template?